AI and Healthcare

Will AI Replace Doctors? The Case for Autonomous AI in Medicine with Ezekiel Emanuel, MD, PhD

AI and Healthcare

Show Notes

Will AI replace doctors? Ezekiel "Zeke" Emanuel, MD, PhD, thinks autonomous AI will soon manage a lot of what physicians do today, starting with chronic disease and the side effects of chemotherapy, and that the better it gets, the more likely a human override is to add errors rather than catch them. His recent JAMA papers made the argument in print. In this episode of AI and Healthcare, oncologist Sanjay Juneja, MD sits down with Emanuel, an oncologist, bioethicist and Penn's Vice Provost for Global Initiatives, to talk through where autonomous AI in healthcare arrives first, where it will fail, and what is left for physicians when it does.

More from AI and Healthcare

Oct 27, 2026

In this episode of AI and Healthcare, oncologists Sanjay Juneja, MD and Doug Flora, MD sit down with Greg Goldgof, MD, PhD, MS, a computer scientist and board-certified pathologist, to talk about DeepHeme, the AI system his lab built to classify the cells in a bone marrow aspirate, the test at the center of diagnosing leukemia and other blood cancers, and what it took to get it validated and into clinical use. Gregory Goldgof, MD, PhD, MS is Director, Artificial Intelligence, Hematopathology Service, Memorial Sloan Kettering Cancer Center. He is a computer scientist and a pathologist board-certified in clinical pathology and clinical informatics. His lab builds AI tools for hematopathology, hematology and cytology.

Oct 13, 2026

In this episode of AI and Healthcare, oncologists Sanjay Juneja, MD and Doug Flora, MD sit down with Mika Newton, CEO of xCures, to unpack a new AI in Precision Oncology paper on using large language models to turn hundreds of medical records per cancer patient into structured, verifiable healthcare data.

Sep 3, 2026

What if medical scans we already collect contain signals that could predict cancer treatment response, reveal disease risk years earlier, or identify biological patterns the human eye cannot see? In this episode of AI & Healthcare, oncologists Dr. Sanjay Juneja and Dr. Doug Flora, speak with AI and biomedical imaging researcher Anant Madabhushi, PhD about the hidden information inside routine CT scans, retinal images, and pathology slides. They explore how AI could help predict treatment response, detect warning signs of disease, uncover meaningful signals in tumor vessels and surrounding tissue, and expand access in regions facing shortages of radiologists and pathologists. The conversation also examines explainability, automation bias, clinical validation, health equity, and the consequences of waiting too long to use potentially valuable technology. Anant Madabhushi, PhD is the Robert W. Woodruff Professor of Biomedical Engineering at Emory University and Georgia Tech and Executive Director of the Emory Empathetic AI for Health Institute. His work focuses on AI, radiomics, computational pathology, and predicting treatment response from routinely collected medical images. Subscribe for conversations about artificial intelligence, oncology, clinical medicine, and the future of healthcare.

Aug 14, 2026

Medicine is becoming too complex for any one clinician to keep up with alone. AI may soon change that equation. Dr. Francisco Esteva joins Dr. Sanjay Juneja and Dr. Doug Flora to explain how physicians can use AI to research faster, communicate more clearly with patients, automate repetitive work, and build systems that extend their expertise. Francisco began learning these tools around age 60. Today, he's building AI-powered workflows for patient education, YouTube, research, quality control, and automation. You don't have to become an AI expert. But understanding how to use these tools may soon become an essential clinical skill.

Jul 27, 2026

CMS just proposed rules that could decide who gets paid for AI in healthcare, and that's a bigger deal than another “better algorithm” story. Dr. Sanjay Juneja and Dr. Douglas Flora talk with Jordan Johnson (radiation oncology, healthcare finance, compliance and law) about what's actually in the proposal and what happens once it lands. Topics: when does AI actually count as a billable clinical service. Why getting paid also means getting watched more closely. Hospitals leaning toward integrated platforms over one-off point solutions. What to do now, before the rule locks in. Still just a proposal, not law yet, so we should say that somewhere.

See all episodes →